Adonis Georgiadis’ Words That Made Headlines
“Europe must maintain the production of critical medicines within the EU and reduce dependence on third countries. Greece has strongly supported this initiative from day one, and we have fought tirelessly!”
“We will also address the protection of young people from tobacco and alcohol. Greece has already implemented the strictest legislation in the EU and developed advanced digital monitoring platforms. We have done remarkable work, which we will proudly present here in Brussels.”
“Health must be the Alpha and Omega of life, and the new pharmaceutical legislation balances innovation with immediate access to generics after patent expiration.”
Greece Leads Europe in Pharmaceutical Policy
At the European Health Ministers’ Council in Brussels, Adonis Georgiadis highlighted Greece’s role as a European pioneer in pharmaceutical policy.
The Greek government is championing autonomy in pharmaceutical production, ensuring that Europe can rely on itself for critical medicines and reduce dependence on countries outside the EU.
- Data protection for medicines: 8–11 years
- Generics enter the market immediately after patent expiration
- Clear and enforceable rules for EU pharmaceutical markets
“We want Europe to remain a hub for innovative medicines with real added value, while ensuring generics reach patients as soon as possible,” said Georgiadis.
Youth Protection at the Core of Greece’s Health Policy
Greece is setting a new standard for protecting young people from harmful substances. The country has implemented:
- The strictest anti-tobacco and anti-alcohol laws in the EU
- Digital monitoring platforms that track and prevent youth exposure
- Comprehensive awareness campaigns for schools and communities
“Our legislation and programs are a model for Europe. We are taking care of our youth proactively,” Georgiadis emphasized.
This approach demonstrates that Greece is not only leading in policy but also in implementation, bridging innovation and public health.
Health as a European Priority
Adonis Georgiadis strongly advocates that health should be a central priority in the EU budget and policy planning. According to him:
- Health is the Alpha and Omega of life.
- Policies must balance innovation incentives with public access to medicines.
- Clear rules and transparency are critical for market stability and patient trust.
“By prioritizing health in the EU agenda, we ensure a Europe that values its citizens’ wellbeing and strengthens pharmaceutical production locally,” Georgiadis stated.
Greece’s Vision for Innovation and Generics
The Greek government’s strategy ensures a careful balance between innovation and access:
- 8–11 years of patent protection for innovative medicines
- Immediate access to generics after patent expiration
- A regulatory framework that promotes both industry growth and citizen protection
“Greece supports both innovation and generics. This approach ensures patients benefit without stifling pharmaceutical creativity,” Georgiadis said.
With these measures, Greece positions itself as a European leader, showing that a country can foster innovation while protecting citizens and maintaining transparency in healthcare.
Georgiadis’ Closing Words in Brussels
“Our goal is clear: Europe must remain a model of pharmaceutical safety and innovation. Greece is committed to leading by example, protecting its citizens, and ensuring that medicines and healthcare are priorities for the entire Union.”
Through this leadership, Greece under Adonis Georgiadis emerges as a driving force in European health policy, demonstrating that strategic planning, strong legislation, and public protection can go hand in hand with innovation and industrial growth.
Source: pagenews.gr